📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Who is at Risk of Parkinson Disease? Refining the Preclinical Phase of GBA1 and LRRK2 Variant Carriers: a Clinical, Biochemical, and Imaging Approach. (2023)

First Author: Menozzi E

Attributed to: JPND GBA - personalised medicine for Parkinson disease: clinical and therapeutic stratification funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s11910-023-01259-1

PubMed Identifier: 36881256

Publication URI: http://europepmc.org/abstract/MED/36881256

Type: Journal Article/Review

Volume: 23

Parent Publication: Current neurology and neuroscience reports

Issue: 4

ISSN: 1528-4042